2018-2023 Global Neurocutaneous Disorder Market Report (Status and Outlook)

Publisher Name :
Date: 11-Oct-2018
No. of pages: 119

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Neurocutaneous Disorder market for 2018-2023.

Neurocutaneous Disorders are disorders that lead to growth of tumors in various parts of the body. They're caused by the abnormal development of cells in an embryo and characterized by the tumors in various parts of the body (including the nervous system) and by certain differences in the skin. While some can be diagnosed at birth, others don't produce symptoms until later in life. Although neurocutaneous disorders can't be cured, treatments can help manage symptoms and any health problems that occur.

Common neurocutaneous disorders that affect kids include neurofibromatosis, sturge-Weber syndrome, tuberous sclerosis (TS), ataxia-telangiectasia (A-T) and von Hippel-Lindau disease (VHL). Symptoms vary widely from condition to condition, and they affect different kids in different ways. Often, the full effects of these diseases — even if detected at birth — don't emerge until a child grows up. The educational, social, and physical problems that the conditions cause must be managed throughout a child's life.

Over the next five years, LPI(LP Information) projects that Neurocutaneous Disorder will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Neurocutaneous Disorder market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

- Tuberous Sclerosis (TS)

- Neurofibromatosis (NF)

- Von Hippel-Lindau Disease (VHL)

- Ataxia-Telangiectasia (A-T)

Segmentation by application:

- Hospital & Clinics

- Diagnostic Centers

We can also provide the customized separate regional or country-level reports, for the following regions:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

- Valeant Pharmaceuticals

- Allergan

- Syneron Medical

- Medtronic

- Cutera

- St Jude Medical

- Pfizer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Neurocutaneous Disorder market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Neurocutaneous Disorder market by identifying its various subsegments.

- Focuses on the key global Neurocutaneous Disorder players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Neurocutaneous Disorder with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Neurocutaneous Disorder submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Neurocutaneous Disorder Market Report (Status and Outlook)

Table of Contents

2018-2023 Global Neurocutaneous Disorder Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurocutaneous Disorder Market Size 2013-2023
2.1.2 Neurocutaneous Disorder Market Size CAGR by Region
2.2 Neurocutaneous Disorder Segment by Type
2.2.1 Tuberous Sclerosis (TS)
2.2.2 Neurofibromatosis (NF)
2.2.3 Sturge-Weber Syndrome Disease
2.2.4 Von Hippel-Lindau Disease (VHL)
2.2.5 Ataxia-Telangiectasia (A-T)
2.3 Neurocutaneous Disorder Market Size by Type
2.3.1 Global Neurocutaneous Disorder Market Size Market Share by Type (2013-2018)
2.3.2 Global Neurocutaneous Disorder Market Size Growth Rate by Type (2013-2018)
2.4 Neurocutaneous Disorder Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Diagnostic Centers
2.5 Neurocutaneous Disorder Market Size by Application
2.5.1 Global Neurocutaneous Disorder Market Size Market Share by Application (2013-2018)
2.5.2 Global Neurocutaneous Disorder Market Size Growth Rate by Application (2013-2018)

3 Global Neurocutaneous Disorder by Players
3.1 Global Neurocutaneous Disorder Market Size Market Share by Players
3.1.1 Global Neurocutaneous Disorder Market Size by Players (2016-2018)
3.1.2 Global Neurocutaneous Disorder Market Size Market Share by Players (2016-2018)
3.2 Global Neurocutaneous Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Neurocutaneous Disorder by Regions
4.1 Neurocutaneous Disorder Market Size by Regions
4.2 Americas Neurocutaneous Disorder Market Size Growth
4.3 APAC Neurocutaneous Disorder Market Size Growth
4.4 Europe Neurocutaneous Disorder Market Size Growth
4.5 Middle East & Africa Neurocutaneous Disorder Market Size Growth

5 Americas
5.1 Americas Neurocutaneous Disorder Market Size by Countries
5.2 Americas Neurocutaneous Disorder Market Size by Type
5.3 Americas Neurocutaneous Disorder Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Neurocutaneous Disorder Market Size by Countries
6.2 APAC Neurocutaneous Disorder Market Size by Type
6.3 APAC Neurocutaneous Disorder Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Neurocutaneous Disorder by Countries
7.2 Europe Neurocutaneous Disorder Market Size by Type
7.3 Europe Neurocutaneous Disorder Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Neurocutaneous Disorder by Countries
8.2 Middle East & Africa Neurocutaneous Disorder Market Size by Type
8.3 Middle East & Africa Neurocutaneous Disorder Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Neurocutaneous Disorder Market Forecast
10.1 Global Neurocutaneous Disorder Market Size Forecast (2018-2023)
10.2 Global Neurocutaneous Disorder Forecast by Regions
10.2.1 Global Neurocutaneous Disorder Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Neurocutaneous Disorder Forecast by Type
10.8 Global Neurocutaneous Disorder Forecast by Application

11 Key Players Analysis
11.1 Valeant Pharmaceuticals
11.1.1 Company Details
11.1.2 Neurocutaneous Disorder Product Offered
11.1.3 Valeant Pharmaceuticals Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Valeant Pharmaceuticals News
11.2 Allergan
11.2.1 Company Details
11.2.2 Neurocutaneous Disorder Product Offered
11.2.3 Allergan Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Allergan News
11.3 Syneron Medical
11.3.1 Company Details
11.3.2 Neurocutaneous Disorder Product Offered
11.3.3 Syneron Medical Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Syneron Medical News
11.4 Medtronic
11.4.1 Company Details
11.4.2 Neurocutaneous Disorder Product Offered
11.4.3 Medtronic Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Medtronic News
11.5 Cutera
11.5.1 Company Details
11.5.2 Neurocutaneous Disorder Product Offered
11.5.3 Cutera Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Cutera News
11.6 St Jude Medical
11.6.1 Company Details
11.6.2 Neurocutaneous Disorder Product Offered
11.6.3 St Jude Medical Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 St Jude Medical News
11.7 Pfizer
11.7.1 Company Details
11.7.2 Neurocutaneous Disorder Product Offered
11.7.3 Pfizer Neurocutaneous Disorder Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Pfizer News
...

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Neurocutaneous Disorder
Figure Neurocutaneous Disorder Report Years Considered
Figure Market Research Methodology
Figure Global Neurocutaneous Disorder Market Size Growth Rate 2013-2023 ($ Millions)
Table Neurocutaneous Disorder Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Tuberous Sclerosis (TS)
Table Major Players of Neurofibromatosis (NF)
Table Major Players of Sturge-Weber Syndrome Disease
Table Major Players of Von Hippel-Lindau Disease (VHL)
Table Major Players of Ataxia-Telangiectasia (A-T)
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Neurocutaneous Disorder Market Size Market Share by Type (2013-2018)
Figure Global Neurocutaneous Disorder Market Size Market Share by Type (2013-2018)
Figure Global Tuberous Sclerosis (TS) Market Size Growth Rate
Figure Global Neurofibromatosis (NF) Market Size Growth Rate
Figure Global Sturge-Weber Syndrome Disease Market Size Growth Rate
Figure Global Von Hippel-Lindau Disease (VHL) Market Size Growth Rate
Figure Global Ataxia-Telangiectasia (A-T) Market Size Growth Rate
Figure Neurocutaneous Disorder Consumed in Hospital & Clinics
Figure Global Neurocutaneous Disorder Market: Hospital & Clinics (2013-2018) ($ Millions)
Figure Global Hospital & Clinics YoY Growth ($ Millions)
Figure Neurocutaneous Disorder Consumed in Diagnostic Centers
Figure Global Neurocutaneous Disorder Market: Diagnostic Centers (2013-2018) ($ Millions)
Figure Global Diagnostic Centers YoY Growth ($ Millions)
Table Global Neurocutaneous Disorder Market Size by Application (2013-2018) ($ Millions)
Table Global Neurocutaneous Disorder Market Size Market Share by Application (2013-2018)
Figure Global Neurocutaneous Disorder Market Size Market Share by Application (2013-2018)
Figure Global Neurocutaneous Disorder Market Size in Hospital & Clinics Growth Rate
Figure Global Neurocutaneous Disorder Market Size in Diagnostic Centers Growth Rate
Table Global Neurocutaneous Disorder Revenue by Players (2016-2018) ($ Millions)
Table Global Neurocutaneous Disorder Revenue Market Share by Players (2016-2018)
Figure Global Neurocutaneous Disorder Revenue Market Share by Players in 2017
Table Global Neurocutaneous Disorder Key Players Head office and Products Offered
Table Neurocutaneous Disorder Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Neurocutaneous Disorder Market Size by Regions 2013-2018 ($ Millions)
Table Global Neurocutaneous Disorder Market Size Market Share by Regions 2013-2018
Figure Global Neurocutaneous Disorder Market Size Market Share by Regions 2013-2018
Figure Americas Neurocutaneous Disorder Market Size 2013-2018 ($ Millions)
Figure APAC Neurocutaneous Disorder Market Size 2013-2018 ($ Millions)
Figure Europe Neurocutaneous Disorder Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Neurocutaneous Disorder Market Size 2013-2018 ($ Millions)
Table Americas Neurocutaneous Disorder Market Size by Countries (2013-2018) ($ Millions)
Table Americas Neurocutaneous Disorder Market Size Market Share by Countries (2013-2018)
Figure Americas Neurocutaneous Disorder Market Size Market Share by Countries in 2017
Table Americas Neurocutaneous Disorder Market Size by Type (2013-2018) ($ Millions)
Table Americas Neurocutaneous Disorder Market Size Market Share by Type (2013-2018)
Figure Americas Neurocutaneous Disorder Market Size Market Share by Type in 2017
Table Americas Neurocutaneous Disorder Market Size by Application (2013-2018) ($ Millions)
Table Americas Neurocutaneous Disorder Market Size Market Share by Application (2013-2018)
Figure Americas Neurocutaneous Disorder Market Size Market Share by Application in 2017
Figure United States Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Canada Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Table APAC Neurocutaneous Disorder Market Size by Countries (2013-2018) ($ Millions)
Table APAC Neurocutaneous Disorder Market Size Market Share by Countries (2013-2018)
Figure APAC Neurocutaneous Disorder Market Size Market Share by Countries in 2017
Table APAC Neurocutaneous Disorder Market Size by Type (2013-2018) ($ Millions)
Table APAC Neurocutaneous Disorder Market Size Market Share by Type (2013-2018)
Figure APAC Neurocutaneous Disorder Market Size Market Share by Type in 2017
Table APAC Neurocutaneous Disorder Market Size by Application (2013-2018) ($ Millions)
Table APAC Neurocutaneous Disorder Market Size Market Share by Application (2013-2018)
Figure APAC Neurocutaneous Disorder Market Size Market Share by Application in 2017
Figure China Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Japan Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Korea Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure India Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Australia Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Table Europe Neurocutaneous Disorder Market Size by Countries (2013-2018) ($ Millions)
Table Europe Neurocutaneous Disorder Market Size Market Share by Countries (2013-2018)
Figure Europe Neurocutaneous Disorder Market Size Market Share by Countries in 2017
Table Europe Neurocutaneous Disorder Market Size by Type (2013-2018) ($ Millions)
Table Europe Neurocutaneous Disorder Market Size Market Share by Type (2013-2018)
Figure Europe Neurocutaneous Disorder Market Size Market Share by Type in 2017
Table Europe Neurocutaneous Disorder Market Size by Application (2013-2018) ($ Millions)
Table Europe Neurocutaneous Disorder Market Size Market Share by Application (2013-2018)
Figure Europe Neurocutaneous Disorder Market Size Market Share by Application in 2017
Figure Germany Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure France Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure UK Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Italy Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Russia Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Spain Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Neurocutaneous Disorder Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Neurocutaneous Disorder Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Neurocutaneous Disorder Market Size Market Share by Countries in 2017
Table Middle East & Africa Neurocutaneous Disorder Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Neurocutaneous Disorder Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Neurocutaneous Disorder Market Size Market Share by Type in 2017
Table Middle East & Africa Neurocutaneous Disorder Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Neurocutaneous Disorder Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Neurocutaneous Disorder Market Size Market Share by Application in 2017
Figure Egypt Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Israel Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Neurocutaneous Disorder Market Size Growth 2013-2018 ($ Millions)
Figure Global Neurocutaneous Disorder arket Size Forecast (2018-2023) ($ Millions)
Table Global Neurocutaneous Disorder Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Neurocutaneous Disorder Market Size Market Share Forecast by Regions
Figure Americas Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure APAC Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Europe Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure United States Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Canada Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Mexico Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Brazil Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure China Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Japan Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Korea Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure India Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Australia Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Germany Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure France Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure UK Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Italy Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Russia Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Spain Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Egypt Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure South Africa Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Israel Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure Turkey Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Figure GCC Countries Neurocutaneous Disorder Market Size 2018-2023 ($ Millions)
Table Global Neurocutaneous Disorder Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Neurocutaneous Disorder Market Size Market Share Forecast by Type (2018-2023)
Table Global Neurocutaneous Disorder Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Neurocutaneous Disorder Market Size Market Share Forecast by Application (2018-2023)
Table Valeant Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Valeant Pharmaceuticals Neurocutaneous Disorder Revenue and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals Neurocutaneous Disorder Market Share (2016-2018)
Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Allergan Neurocutaneous Disorder Revenue and Gross Margin (2016-2018)
Figure Allergan Neurocutaneous Disorder Market Share (2016-2018)
Table Syneron Medical Basic Information, Head Office, Major Market Areas and Its Competitors
Table Syneron Medical Neurocutaneous Disorder Revenue and Gross Margin (2016-2018)
Figure Syneron Medical Neurocutaneous Disorder Market Share (2016-2018)
Table Medtronic Basic Information, Head Office, Major Market Areas and Its Competitors
Table Medtronic Neurocutaneous Disorder Revenue and Gross Margin (2016-2018)
Figure Medtronic Neurocutaneous Disorder Market Share (2016-2018)
Table Cutera Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cutera Neurocutaneous Disorder Revenue and Gross Margin (2016-2018)
Figure Cutera Neurocutaneous Disorder Market Share (2016-2018)
Table St Jude Medical Basic Information, Head Office, Major Market Areas and Its Competitors
Table St Jude Medical Neurocutaneous Disorder Revenue and Gross Margin (2016-2018)
Figure St Jude Medical Neurocutaneous Disorder Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Neurocutaneous Disorder Revenue and Gross Margin (2016-2018)
Figure Pfizer Neurocutaneous Disorder Market Share (2016-2018)
  • Global Nucleic Acid Testing Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 93
    A nucleic acid test (NAT) or nucleic acid amplification test (NAAT) is a technique utilized to detect a particular nucleic acid, virus, or bacteria which acts as a pathogen in blood, tissue, urine, etc. The NAT system differs from other tests in that it detects genetic materials rather than antigens or antibodies. Detection of genetic materials allows an early diagnosis of a disease because the detection of antigens requires time for antigens to appear in the bloodstream. According to the......
  • Global Neurosurgery Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 119
    Neurosurgery is a complex surgical procedure that involves diagnosis, treatment, and rehabilitation of disorders affecting any region of the nervous system. Some of the common neurosurgeries are endovascular neurosurgery, stereotactic neurosurgery, oncological neurosurgery, craniotomy, and neuroendoscopy. These surgeries are performed to treat neurological disorders, tumors, trauma, and injuries. The devices used to perform neurosurgeries are neurosurgical devices. Neuroendoscope is one ......
  • Global Nanoparticles in Biotechnology and Pharmaceuticals Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 4900 Onwards        Pages: 129
    Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules The......
  • Global MRSA Testing Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 105
    MRSA (Methicillin-resistant Staphylococcus aureus) testing is utilized to detect MRSAs and no other microbes. It is prominently employed in hospitals, especially in intensive care units to inhibit MRSA from spreading to other patients. On larger levels such as community and society, the MRSA test can be employed to detect the source of an outbreak. For a national level addition, testing and research may help scientists determine the cause. In 2018, the global MRSA Testing market si......
  • Global Sacral Nerve Stimulation Devices Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 4900 Onwards        Pages: 113
    Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is comple......
  • Global Sacral Nerve Stimulation Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 97
    Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is comple......
  • Global Bioabsorbable Stents Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 4900 Onwards        Pages: 110
    Bioabsorbable Stents Market are defined as medical devices that are implanted into the blood vessels or other internal ducts for the treatment of blocked vessels or arteries. It is typically made up of metal mesh and remains in the body permanently or until removed via surgical intervention. A biodegradable stent on the other hand is made of biological material, which is dissolved or absorbed in the body. These stents eliminate the requirement of surgery to remove stents. By absorption ra......
  • Global Gastrointestinal Therapeutics Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 105
    Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec. Accounting for ......
  • Global GERD Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 97
    Gastroesophageal reflux disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the stomach and esophagus. It occurs when acidic stomach juices, or food and fluids flow back up into the food pipe (esophagus). The backwash irritates the lining of the esophagus and causes GERD. It affects all ages from infants to older adults. The symptoms of GERD include difficulty while swallowing (dysphagia), heartburn sensation, regurgitation......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs